Skip to content

Comparison Between the Effect of Two Different Doses of Oral Melatonin on Sleep Quality After Total Hip Arthroplasty

Comparison Between the Effect of Two Different Doses of Oral Melatonin on Sleep Quality After Total Hip Arthroplasty A Randomized Placebo-Controlled Double-Blind Trial

Status
Not yet recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07732725
Enrollment
150
Registered
2026-07-29
Start date
2026-08-04
Completion date
2026-11-04
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Disturbance

Brief summary

Considering the fact that melatonin was safely and effectively used in higher doses in multiple surgical conditions , the present study hypothesized that increasing melatonin dose in THA would have better benefits for patients.

Detailed description

Considering the fact that melatonin was safely and effectively used in higher doses in multiple surgical conditions, the present study hypothesized that increasing melatonin dose in THA would have better benefits for patients. Also, The present study aimed to assess the value of oral melatonin 5mg and 10mg given perioperatively on sleep quality in patients submitted to total hip arthroplasty.

Interventions

Melatonin 5 mg and one placebo sugar tablet oral tablet, two hours preoperatively and for 14 nights postoperatively.

Two melatonin 5 mg oral tablet, two hours preoperatively and for 14 nights postoperatively.

OTHERPlacebo

Two placebo sugar tablets, two hours preoperatively and for 14 nights postoperatively.

Sponsors

Benha University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Elective unilateral total hip arthroplasty.

Exclusion criteria

* Revision arthroplasty * documented sleep disorders requiring treatment, * use of other sleep medications preoperatively * known melatonin allergy or contraindication.

Design outcomes

Primary

MeasureTime frameDescription
Sleep Quality14 daysPatient-Reported Outcomes Measurement Information System (PROMIS) for sleep quality

Countries

Egypt

Contacts

CONTACTNourhan Amer, PhD
+20 11 11337700

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026